Shorter treatment course may ease side effects for AML patients
NCT ID NCT05833438
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way of giving two drugs—venetoclax and azacitidine—to adults with acute myeloid leukemia (AML) who are not healthy enough for standard chemotherapy. Instead of the usual 7 days of azacitidine, this approach uses only 5 days per cycle to try to reduce infections and hospital stays. The goal is to see if the shorter regimen still works well while being easier to tolerate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carl-Thiem-Klinikum Cottbus gGmbH
Cottbus, 03048, Germany
-
Helios Klinikum Berlin-Buch Klinik für Hämatologie und Stammzelltransplantation
Berlin, 13125, Germany
-
Kliniken Maria Hilf GmbH, Klinik für Hämatologie, Onkologie und Gastroenterologie
Mönchengladbach, 41063, Germany
-
Kliniken Sindelfingen,Medizinische Klinik I
Sindelfingen, 71065, Germany
-
Klinikum Chemnitz gGmbH Klinik für lnnere Medizin Ill
Chemnitz, 09116, Germany
-
Klinikum rechts der lsar der TU München, Klinik und Poliklinik für lnnere Medizin Ill
München, 81675, Germany
-
Rotkreuzklinikum München, III. Medizinische Abteilung
München, 80364, Germany
-
Universitatsklinikum Carl Gustav Carus Dresden an der TU Dresden Medizinische Klinik und Poliklinik 1 Bereich Hamatologie
Dresden, 01307, Germany
-
Universitätsklinikum Heidelberg, Innere Medizin V; Klinik für Hämatologie, Onkologie und Rheumatologie
Heidelberg, 69120, Germany
-
Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie
Leipzig, Germany